We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A pharmacy chain operator that brought antitrust class action lawsuits against more than a dozen generics manufacturers earlier this week has added three more — Actavis Holdco, Lannett and Epic Pharma — claiming they colluded to raise the prices of the gallbladder stone treatment ursodiol. Read More
The Association of the British Pharmaceutical Industry will run advertisements later this month in three medical journals listing Astellas UK and Gedeon Richter as in breach of the ABPI’s Code of Practice, through the association’s Prescription Medicines Code of Practice Authority. Read More
A pharmacy chain brought class action suits against 13 generics manufacturers — including Mylan, Sandoz, and Teva — claiming they conspired to raise prices of six drugs, including blood pressure medications, antidepressants and corticosteroids. Read More
Janssen Biotech is suing Celltrion and Hospira in the latest of a series of lawsuits related to its blockbuster Remicade (infliximab) therapy. Read More
GlaxoSmithKline and ViiV Healthcare redeemed a priority review voucher for their application for a single-tablet antiretroviral regimen of Tivicay (dolutegravir) and Edurant (rilpivirine) for maintenance treatment of HIV-1 infections. The voucher allows for an expedited six-month review — cutting four months from the standard review. Read More